WO2011135591A3 - Novel tablet composition of polyallylamine polymers - Google Patents

Novel tablet composition of polyallylamine polymers Download PDF

Info

Publication number
WO2011135591A3
WO2011135591A3 PCT/IN2011/000297 IN2011000297W WO2011135591A3 WO 2011135591 A3 WO2011135591 A3 WO 2011135591A3 IN 2011000297 W IN2011000297 W IN 2011000297W WO 2011135591 A3 WO2011135591 A3 WO 2011135591A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
cellulose
tablet composition
substantially free
novel tablet
Prior art date
Application number
PCT/IN2011/000297
Other languages
French (fr)
Other versions
WO2011135591A2 (en
Inventor
Vivekanandan Sundaramoorthy
Anandsenthilvel Palanisamy
Sampathkumar Devarajan
Jeffrey Stuart Bergman
Original Assignee
Shasun Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shasun Pharmaceuticals Limited filed Critical Shasun Pharmaceuticals Limited
Publication of WO2011135591A2 publication Critical patent/WO2011135591A2/en
Publication of WO2011135591A3 publication Critical patent/WO2011135591A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical compositions comprising polyallylamine polymer, binder, disintegrant, diluents and pharmaceutically acceptable inert excipients, substantially free of cellulose or cellulose derivatives and stearic acid. The polyallylamine polymer includes such as sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride. Particularly, the present invention provides pharmaceutical composition comprising a tablet core substantially free of cellulose. Moreover, the present invention relates to a process of preparing the pharmaceutical composition in tablet form by direct compression method.
PCT/IN2011/000297 2010-04-29 2011-04-29 Novel tablet composition of polyallylamine polymers WO2011135591A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN227CH2010 2010-04-29
IN227/CHE/2010 2010-04-29

Publications (2)

Publication Number Publication Date
WO2011135591A2 WO2011135591A2 (en) 2011-11-03
WO2011135591A3 true WO2011135591A3 (en) 2012-03-08

Family

ID=44861985

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000297 WO2011135591A2 (en) 2010-04-29 2011-04-29 Novel tablet composition of polyallylamine polymers

Country Status (1)

Country Link
WO (1) WO2011135591A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2591768B1 (en) * 2011-11-14 2014-07-16 Deva Holding Anonim Sirketi Single unit dosage formulations of sevelamer and fat soluble vitamins and surface active agents
RS59365B1 (en) * 2012-06-15 2019-11-29 Pharmathen Sa Pharmaceutical composition containing phosphate binding polymer
CN102908325B (en) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 Sevelamer carbonate medical tablet composition and preparation method thereof
EP2875807B1 (en) 2013-11-20 2021-03-24 Sanovel Ilac Sanayi ve Ticaret A.S. Tablet formulation of colesevelam
CN104546781A (en) * 2014-12-22 2015-04-29 青岛正大海尔制药有限公司 Sevelamer carbonate tablet and preparation method thereof
BR112017018316A2 (en) * 2015-02-27 2018-04-17 Ebbu Llc compositions comprising combinations of purified cannabinoids with at least one flavonoid, terpene or mineral
EP3503875A4 (en) 2016-08-29 2020-06-24 Canopy Growth Corporation Water soluble compositions comprising purified cannabinoids
CN112972407A (en) * 2019-12-18 2021-06-18 南京恒生制药有限公司 Sevelamer carbonate tablet composition and preparation method thereof
CN111773190A (en) * 2020-06-24 2020-10-16 北京瑞迪道森医药科技有限公司 Sevelamer carbonate tablet for improving safety of preparation and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100008988A1 (en) * 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
WO2010041268A2 (en) * 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
US20110064820A1 (en) * 2006-09-01 2011-03-17 Ashok Omray Pharmaceutical Compositions Comprising Phosphate-Binding Polymer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110064820A1 (en) * 2006-09-01 2011-03-17 Ashok Omray Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
US20100008988A1 (en) * 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
WO2010041268A2 (en) * 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers

Also Published As

Publication number Publication date
WO2011135591A2 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
WO2011135591A3 (en) Novel tablet composition of polyallylamine polymers
UA106878C2 (en) Pharmaceutical formulation comprising 4-[3-(4-cyclopropanecarbonyl- piperazine-1-carbonyl) -4-fluoro-benzyl]-2h-phthalazin-1-oh or salt thereof or solvate in a solid dispersion with a matrix polymer copovidone
WO2011062965A3 (en) Targeting monomers and polymers having targeting blocks
WO2010146179A3 (en) Solid pharmaceutical composition comprising rivaroxaban
MY173823A (en) Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
WO2011130615A3 (en) Preparation of lacosamide
CA2863376A1 (en) Gastroretentive tablets
WO2010092090A3 (en) Novel salts of sitagliptin
WO2014207664A3 (en) Stable pharmaceutical composition of asenapine
WO2011146583A3 (en) Nanoparticulate cinacalcet formulations
WO2012085927A3 (en) Tadalafil compositions
WO2010082220A3 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2011104652A3 (en) Veterinary compositions
WO2011101863A3 (en) Extended release pharmaceutical compositions of lacosamide
GEP20135859B (en) Stable combined pharmaceutical composition
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
TR200904159A1 (en) Modified release emoxipine formulations.
WO2011008666A3 (en) 3-phenoxymethylpyrrolidine compounds
CA2863371A1 (en) Pregabalin gr tablets
WO2011155728A3 (en) Composition for preventing or treating osteoporosis, and manufacturing method therefor
WO2011098194A3 (en) Pharmaceutical mini-tablets for sustained release of flecainide acetate
WO2012076961A3 (en) Carnosine - hyaluronic acid mixtures and their use
NZ607225A (en) Multiple unit tablet composition
UA105285C2 (en) Solid pharmaceutical composition comprising ramipril and amlodipine besilate and method for its preparation
WO2012108631A3 (en) Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11774547

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11774547

Country of ref document: EP

Kind code of ref document: A2